Sei Hyun Baik Selected Research

P 569

8/2014

Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sei Hyun Baik Research Topics

Disease

40	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2009
34	Insulin Resistance 06/2022 - 03/2010
24	Obesity 01/2022 - 01/2008
20	Inflammation (Inflammations) 06/2022 - 03/2010
18	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 12/2005
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2007
16	Non-alcoholic Fatty Liver Disease 07/2021 - 07/2004
13	Atherosclerosis 10/2020 - 03/2006
8	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 06/2011
7	Diabetes Mellitus 11/2022 - 01/2017
6	Dementia (Dementias) 11/2022 - 12/2016
6	Diabetes Complications 01/2021 - 02/2018
6	Glucose Intolerance 09/2020 - 03/2010
5	Stroke (Strokes) 01/2022 - 06/2019
5	Myocardial Infarction 01/2022 - 01/2018
5	Hypertension (High Blood Pressure) 01/2022 - 08/2006
4	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 11/2019
4	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 08/2010
3	Dyslipidemias (Dyslipidemia) 11/2022 - 01/2020
3	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 10/2016
3	Metabolic Diseases (Metabolic Disease) 11/2021 - 01/2019
3	Neoplasms (Cancer) 01/2020 - 12/2005
3	Diabetic Nephropathies (Diabetic Nephropathy) 04/2019 - 01/2005
3	Abdominal Obesity 01/2019 - 01/2013
3	Prediabetic State (Prediabetes) 01/2014 - 03/2006
2	Chronic Renal Insufficiency 01/2021 - 04/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 01/2020
2	Fatty Liver 09/2020 - 01/2008
2	Renal Insufficiency (Renal Failure) 01/2020 - 01/2018
2	Heart Failure 01/2020 - 11/2019
2	Ischemic Stroke 11/2019 - 01/2018
2	Hyperglycemia 10/2018 - 12/2012
2	Body Weight (Weight, Body) 09/2018 - 10/2012
2	Albuminuria 01/2018 - 10/2016
2	Atherosclerotic Plaque (Atheroma) 03/2013 - 01/2011

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 08/2006
18	C-Reactive ProteinIBA 10/2018 - 03/2010
11	Insulin (Novolin)FDA Link 12/2021 - 02/2009
10	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2006
10	Triglycerides (Triacylglycerol)IBA 11/2021 - 03/2010
10	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 08/2010
10	AdiponectinIBA 12/2015 - 03/2006
9	AdipokinesIBA 11/2019 - 04/2011
8	Proteins (Proteins, Gene)FDA Link 09/2018 - 10/2012
7	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 06/2017
7	Indicators and Reagents (Reagents)IBA 12/2021 - 05/2014
6	Vitamin D FDA LinkGeneric 06/2022 - 01/2013
6	CholesterolIBA 01/2021 - 08/2006
6	Pharmaceutical PreparationsIBA 01/2019 - 04/2012
5	Blood Glucose (Blood Sugar)IBA 11/2022 - 02/2009
5	LDL CholesterolIBA 01/2022 - 01/2011
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 10/2012
5	LipidsIBA 09/2020 - 09/2013
5	CreatinineIBA 04/2019 - 10/2016
5	HDL CholesterolIBA 02/2017 - 03/2010
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2011
4	LC15-0444IBA 01/2021 - 07/2014
4	TransferasesIBA 10/2020 - 01/2020
4	alpha-2-HS-GlycoproteinIBA 09/2018 - 09/2013
4	EnzymesIBA 02/2018 - 01/2008
4	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2017 - 07/2014
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2021 - 11/2011
3	PalmitatesIBA 09/2020 - 01/2013
3	JNK Mitogen-Activated Protein KinasesIBA 09/2020 - 09/2015
3	AlbuminsIBA 01/2018 - 01/2005
3	Receptor for Advanced Glycation End ProductsIBA 01/2018 - 02/2012
3	Chemotactic FactorsIBA 01/2017 - 09/2015
3	hydroxide ionIBA 11/2015 - 01/2013
3	Fatty Acids (Saturated Fatty Acids)IBA 09/2015 - 07/2004
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2015 - 01/2008
3	Selenoprotein PIBA 01/2014 - 01/2013
3	ProgranulinsIBA 01/2014 - 01/2013
2	IodineIBA 09/2022 - 10/2020
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2022 - 01/2022
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 10/2016
2	GinsenosidesIBA 09/2020 - 07/2020
2	AntioxidantsIBA 07/2020 - 11/2012
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 03/2010
2	voglibose (Basen)IBA 01/2019 - 01/2015
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 01/2014
2	Adenosine Monophosphate (AMP)IBA 01/2019 - 01/2014
2	Alanine Transaminase (SGPT)IBA 10/2018 - 01/2018
2	Insulin Glargine (Lantus)FDA Link 01/2018 - 01/2015
2	Pioglitazone (Actos)FDA Link 06/2017 - 11/2010
2	VildagliptinIBA 06/2017 - 11/2010
2	Angiotensin Receptor AntagonistsIBA 10/2016 - 11/2011
2	HDL LipoproteinsIBA 11/2015 - 12/2005
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 04/2015 - 07/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2015 - 01/2011
2	Nonesterified Fatty Acids (NEFA)IBA 06/2014 - 10/2012
2	Messenger RNA (mRNA)IBA 09/2013 - 01/2013
2	ApolipoproteinsIBA 09/2013 - 10/2012
2	LeptinIBA 09/2013 - 03/2011
2	25-hydroxyvitamin DIBA 04/2013 - 01/2013
2	PPAR alphaIBA 01/2008 - 07/2004

Therapy/Procedure

7	Therapeutics 09/2021 - 11/2010
5	Glycemic Control 01/2021 - 06/2013
2	Thyroidectomy 01/2022 - 10/2016
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 11/2019
1	Punctures 11/2022